Tamara Young
Overview
Explore the profile of Tamara Young including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liao J, Kang A, Xia C, Young T, Di Tanna G, Arnott C, et al.
Diabetes Metab
. 2022 Feb;
48(4):101331.
PMID: 35172198
Aim: Canagliflozin reduces the risk, and progression, of diabetic kidney disease. We hypothesized that it may improve the microvascular complication of neuropathy. Methods: The CREDENCE trial randomized participants with type...
2.
Zhang H, Rogers K, Sukkar L, Jun M, Kang A, Young T, et al.
J Clin Transl Endocrinol
. 2020 Dec;
22:100240.
PMID: 33294382
Aims: To use linked routinely-collected health data to estimate diabetes prevalence and incidence in an Australian cohort of adults aged ≥45 years, and examine risk factors associated with incident disease....
3.
Sukkar L, Young T, Jardine M
Kidney Blood Press Res
. 2020 Dec;
45(6):823-836.
PMID: 33271545
Background: Type 2 diabetes mellitus (T2DM) is frequently associated with the development of cardiovascular disease and chronic kidney disease (CKD). Some newer glucose-lowering agents confer both cardiac and kidney benefits,...
4.
Garcia M, Salazar R, Wilson T, Lucas S, Herbert G, Young T, et al.
Toxicol Sci
. 2020 Nov;
179(1):121-134.
PMID: 33146391
Exposure to air pollutants such as ozone (O3) is associated with adverse pregnancy outcomes, including higher incidence of gestational hypertension, preeclampsia, and peripartum cardiomyopathy; however, the underlying mechanisms of this...
5.
Kang A, Sukkar L, Hockham C, Jun M, Young T, Scaria A, et al.
Intern Med J
. 2020 Oct;
52(5):808-817.
PMID: 33012112
Background And Aim: To determine risk factors for incident chronic kidney disease (CKD) in a large population-based cohort. Methods: This prospective opt-in population-based cohort study is based on the 45...
6.
Li C, Zhou Z, Neuen B, Yu J, Huang Y, Young T, et al.
Diabetes Obes Metab
. 2020 Sep;
23(1):252-257.
PMID: 32954617
Sodium-glucose co-transporter-2 (SGLT2) inhibitors are effective for the treatment of macrovascular complications and nephropathy in type 2 diabetes, but effects on microvascular eye outcomes are unclear. We conducted a systematic...
7.
Xie Y, Baker J, Young T, Jun M, Sukkar L, Campain A, et al.
Diabetes Care
. 2020 Sep;
43(11):e185-e187.
PMID: 32928956
No abstract available.
8.
Foote C, Hockham C, Sukkar L, Campain A, Kang A, Young T, et al.
JMIR Res Protoc
. 2020 Apr;
9(4):e15646.
PMID: 32285803
Background: Chronic kidney disease (CKD) and diabetes are the major causes of death and disability worldwide. They are associated with high health service utilization persisting over many years. Their slow...
9.
Sukkar L, Kang A, Hockham C, Young T, Jun M, Foote C, et al.
Diabetes Care
. 2020 Mar;
43(5):982-990.
PMID: 32161053
Objective: To determine the incidence of and factors associated with an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m in people with diabetes. Research Design And Methods: We identified people...
10.
Neuen B, Young T, Heerspink H, Neal B, Perkovic V, Billot L, et al.
Lancet Diabetes Endocrinol
. 2019 Sep;
7(11):845-854.
PMID: 31495651
Background: The effects of sodium-glucose co-transporter-2 (SGLT2) inhibitors on kidney failure, particularly the need for dialysis or transplantation or death due to kidney disease, is uncertain. Additionally, previous studies have...